Larvol Delta - FDA-Grants-Priority-Review-for-Pfizers-TALZENNA-Plus-XTANDI-for-the-Treatment-of-Metastatic-Prostate-Cancer

Talzenna (talazoparib) - Pfizer

https://investors.pfizer.com/Investors/news-events/News/news-details/2026/FDA-Grants-Priority-Review-for-Pfizers-TALZENNA-Plus-XTANDI-for-the-Treatment-of-Metastatic-Prostate-Cancer/default.aspx

Jul 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next